Looking Into Medtronic's Recent Short Interest
Here's Why We're Wary Of Buying Medtronic's (NYSE:MDT) For Its Upcoming Dividend
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and IDEAYA Biosciences (IDYA)
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?
Investors Five-year Losses Continue as Medtronic (NYSE:MDT) Dips a Further 3.5% This Week, Earnings Continue to Decline
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Least Shorted S&P 500 Stocks in November
Medtronic Analyst Ratings
Truist Securities Adjusts Price Target on Medtronic to $89 From $93, Keeps Hold Rating
DuraStat Launches Commercial Partnership With Medtronic Cranial and Spinal Technologies Business
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $89
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Mizuho Securities Maintains Medtronic(MDT.US) With Buy Rating, Announces Target Price $100
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $96
Unusual Options Activity: BRKR, TSLA and Others Attract Market Bets, BRKR V/OI Ratio Reaches 250.0